Major depressive disorder

Common Name(s)

Major depressive disorder, Major depression

Major depressive disorder is a serious form of depression which involves some combination of the following symptoms: sadness, inability to concentrate, difficulty sleeping (insomnia) or sleeping too much, feeling very tired (fatigue), weight gain or loss, irritability, loss of interest or pleasure in activities, feelings of guilt, worthlessness or hopelessness, and thoughts of suicide. It affects a person’s thoughts, moods, behavior and physical health. A major depressive episode usually lasts more than 2 weeks and interferes with a person’s ability to perform daily functions. Some people may only experience one episode, but others may experience multiple episodes in their lifetime. The cause of major depressive disorder is unknown. It may affect anyone of any age, race, ethnicity, gender or socioeconomic level. Certain factors increase a person’s risk including experiencing traumatic or stressful event(s), having a serious or chronic illness or anxiety related disorder, or having a family history of depression. Those who abuse alcohol or drugs are also at an increased risk.

Major depressive disorder is a serious illness. Without treatment an episode may continue with symptoms becoming increasingly more serious. Major depressive episodes may lead a person to feel that life is not worth living and to commit suicide. If you or someone you know is having thoughts of suicide call a suicide hot line or go to an emergency medical center. It is important to realize that depression is treatable. Treatment may include support groups, medication, talk therapy, or other strategies. Talk to your doctor to decide on the best treatment options if you or a family member is affected by major depression. Support groups are also a good source of up to date information and can help connect you with others affected by depression. See also depression.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Major depressive disorder" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Major depressive disorder" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Major depressive disorder" returned 911 free, full-text research articles on human participants. First 3 results:

[Major depressive disorder in relation with coronary heart disease and stroke in Chinese adults aged 30-79 years].
 

Author(s): C Q Yu, Y P Chen, J Lv, Y Guo, P Sherliker, Z Bian, H Y Zhou, Y L Tan, J S Chen, Z M Chen, L M Li

Journal: Beijing Da Xue Xue Bao. 2016 Jun;48(3):465-71.

 

To investigate the associations of major depressive disorder with coronary heart disease (CHD) and stroke in Chinese adults aged 30-79 years.

Last Updated: 20 Jun 2016

Go To URL
Incidence of Major Depressive Disorder: Variation by Age and Sex in Low-Income Individuals: A Population-Based 10-Year Follow-Up Study.
 

Author(s): Chun-Te Lee, Yi-Cheng Chiang, Jing-Yang Huang, Disline M Tantoh, Oswald N Nfor, Jia-Fu Lee, Cheng-Chen Chang, Yung-Po Liaw

Journal: Medicine (Baltimore). 2016 Apr;95(15):e3110.

 

Major depressive disorder (MDD), the most prevalent mental disorder is a global public health issue. The aim of this study was to assess the association between low income and major depressive disorder (MDD) by age and sex. The National Health Insurance Research Database (NHIRD) of ...

Last Updated: 16 Apr 2016

Go To URL
Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
 

Author(s): Suresh Durgam, Willie Earley, Hua Guo, Dayong Li, György Németh, István Laszlovszky, Maurizio Fava, Stuart A Montgomery

Journal: J Clin Psychiatry. 2016 Mar;77(3):371-8.

 

Cariprazine is an atypical antipsychotic currently under investigation as adjunctive therapy in patients with major depressive disorder (MDD) who have inadequate response to standard antidepressant therapy.

Last Updated: 6 Apr 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Major depressive disorder" returned 140 free, full-text review articles on human participants. First 3 results:

Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA.
 

Author(s): Kun-Yu Tu, Ming-Kung Wu, Yen-Wen Chen, Pao-Yen Lin, Hung-Yu Wang, Ching-Kuan Wu, Ping-Tao Tseng

Journal: Medicine (Baltimore). 2016 Jan;95(4):e2411.

 

An increasing amount of research has focused on insulin-like growth factor-1 (IGF-1) because of multiple neurotrophic effects, including neurogenesis, remyelination, and synaptogenesis. In addition, IGF-1 can mediate an antidepressant effect in patients with major affective disorder, ...

Last Updated: 30 Jan 2016

Go To URL
Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.
 

Author(s): Halle R Amick, Gerald Gartlehner, Bradley N Gaynes, Catherine Forneris, Gary N Asher, Laura C Morgan, Emmanuel Coker-Schwimmer, Erin Boland, Linda J Lux, Susan Gaylord, Carla Bann, Christiane Barbara Pierl, Kathleen N Lohr

Journal:

 

What are the benefits and harms of second generation antidepressants and cognitive behavioral therapies (CBTs) in the initial treatment of a current episode of major depressive disorder in adults?

Last Updated: 9 Dec 2015

Go To URL
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics.
 

Author(s): Rafael T de Sousa, Marcus V Zanetti, Andre R Brunoni, Rodrigo Machado-Vieira

Journal: Curr Neuropharmacol. 2015 ;13(5):616-35.

 

Major depressive disorder (MDD) is associated with a significant burden and costs to the society. As remission of depressive symptoms is achieved in only one-third of the MDD patients after the first antidepressant trial, unsuccessful treatments contribute largely to the observed ...

Last Updated: 15 Oct 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Study of NSI-189 for Major Depressive Disorder
 

Status: Recruiting

Condition Summary: Major Depressive Disorder

 

Last Updated: 16 Sep 2016

Go to URL
A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
 

Status: Recruiting

Condition Summary: Major Depressive Disorder

 

Last Updated: 20 Sep 2016

Go to URL
Study to Treat Major Depressive Disorder (MDD) With a New Medication
 

Status: Recruiting

Condition Summary: Major Depressive Disorder; Depression

 

Last Updated: 13 Apr 2016

Go to URL